Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

University of Saskatchewan

$42,000.00

Small protein-domain affinity reagents and D-proteins

FY 2022-23

Summary
Antibodies are the most widely used affinity reagents, that bind with high affinity and specificity to a target protein of interest. Antibodies have been valuable tools for studying protein function and their role in cell signaling cascades, in both normal and disease states. In addition, these reagents are gaining prominence and utility in diagnosis and therapy, given that they can be used towards detection or inhibition of protein markers of disease.My research program focuses on engineering small, stable protein domains (de novo protein interfaces that can potentially recognize target proteins. However, the small size of these scaffolds presents significant technical challenges in making well-folded affinity reagents. We have previously explored several key factors in designing combinatorial libraries. Structural diversity and the amino acid composition of the mutated interface were determined to be important factors in generating affinity reagents to a wide variety of target proteins.In this proposal, we seek to study the effect of structural rigidity of the scaffold proteins on the effectiveness of generating affinity reagents. Given that molecular recognition requires a conformational fit with the target protein, we hypothesize that rigid scaffolds with minimal conformation flexibility may not be ideal. We propose a systematic study by comparing identical combinatorial libraries based on regular and stabilized versions of a given scaffold protein.We have previously reported the first use of small protein domain scaffolds to generate folded D-protein affinity reagents. D-protein affinity reagents are stable, resistant to proteolysis and non-immunogenic, making these reagents ideal for in vivo applications in molecular imaging. However, this is a nascent field, with several fundamental questions that remain unanswered. What is the fate of the cells that interact with these unnatural proteins? Do these proteins accumulate in cells following receptor-mediated endocytosis? In this proposal, we aim to address these queries by developing D-protein and L-protein affinity reagents that bind to a cell surface receptor EphA2. The proposed studies will have impact in developing effective combinatorial libraries for affinity reagent development and lay the groundwork for development of D-protein affinity reagents.
Program
Discovery Grants Program - Individual
Location
Saskatchewan, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
RGPIN-2017-06195
Name nom
Uppalapati, Maruti
Department département
Pathology and Lab Medicine - Pathology and Lab Medicine
Organization id
16
Institution établissement
University of Saskatchewan
Province en
Saskatchewan
Province fr
Saskatchewan
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2022
Competition year année de concours
2017
Award amount
42000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5300
Research subject group en
Molecular biology
Research subject group fr
Biologie moléculaire
Research subject en
Molecular biology
Research subject fr
Biologie moléculaire
Installment
inst:6;7
Partie
2
Nb partie
7
Application title
Small protein-domain affinity reagents and D-proteins
Application summary
Antibodies are the most widely used affinity reagents, that bind with high affinity and specificity to a target protein of interest. Antibodies have been valuable tools for studying protein function and their role in cell signaling cascades, in both normal and disease states. In addition, these reagents are gaining prominence and utility in diagnosis and therapy, given that they can be used towards detection or inhibition of protein markers of disease.My research program focuses on engineering small, stable protein domains (de novo protein interfaces that can potentially recognize target proteins. However, the small size of these scaffolds presents significant technical challenges in making well-folded affinity reagents. We have previously explored several key factors in designing combinatorial libraries. Structural diversity and the amino acid composition of the mutated interface were determined to be important factors in generating affinity reagents to a wide variety of target proteins.In this proposal, we seek to study the effect of structural rigidity of the scaffold proteins on the effectiveness of generating affinity reagents. Given that molecular recognition requires a conformational fit with the target protein, we hypothesize that rigid scaffolds with minimal conformation flexibility may not be ideal. We propose a systematic study by comparing identical combinatorial libraries based on regular and stabilized versions of a given scaffold protein.We have previously reported the first use of small protein domain scaffolds to generate folded D-protein affinity reagents. D-protein affinity reagents are stable, resistant to proteolysis and non-immunogenic, making these reagents ideal for in vivo applications in molecular imaging. However, this is a nascent field, with several fundamental questions that remain unanswered. What is the fate of the cells that interact with these unnatural proteins? Do these proteins accumulate in cells following receptor-mediated endocytosis? In this proposal, we aim to address these queries by developing D-protein and L-protein affinity reagents that bind to a cell surface receptor EphA2. The proposed studies will have impact in developing effective combinatorial libraries for affinity reagent development and lay the groundwork for development of D-protein affinity reagents.